| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/29/2004 | WO2003053337A3 Therapeutic compositions |
| 01/29/2004 | WO2003052099A3 Methods of parallel gene cloning and analysis |
| 01/29/2004 | WO2003052069A3 FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003046559A3 Individualization of therapy with antiviral agents |
| 01/29/2004 | WO2003046209A3 Method and biosensor for detecting macromolecular biopolymers |
| 01/29/2004 | WO2003042403A3 Biochips for characterizing biological processes |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003034070A3 Immunohistological representation of fibrogenesis in histological tissue cuts |
| 01/29/2004 | WO2003034057A3 Continuous on-line carbon analyzer |
| 01/29/2004 | WO2003027648A3 Compact multiwavelength phase fluorometer |
| 01/29/2004 | WO2003025577A3 Diagnosis and treatment of early pre-type 1 diabetes glial fibrillary acidic protein |
| 01/29/2004 | WO2003025205A3 Extracellular regulated kinase 2 (erk2) |
| 01/29/2004 | WO2003025141A3 Genetic analysis for stratification of cancer risk |
| 01/29/2004 | WO2003020878A3 Amplification and detection reagents for hiv-1 |
| 01/29/2004 | WO2003015617A3 Assay method for alzheimer's disease |
| 01/29/2004 | WO2003008635A3 η-SECRETASE IN VITRO SCREENING ASSAY |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002095406A3 Immobilized asymmetric double lipid layers |
| 01/29/2004 | WO2002086134B1 Buffer solution for electroporation and a method comprising the use of the same |
| 01/29/2004 | WO2002074035A3 Method for generating a hierarchical topological tree of 2d or 3d-structural formulas of chemical compounds for property optimisation of chemical compounds |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002071067A9 Assay system for simultaneous detection and measurement of multiple modified cellular proteins |
| 01/29/2004 | WO2002070737A3 Compositions and methods relating to osteoarthritis |
| 01/29/2004 | WO2002063307A3 Methods of assessing wolframin protein activity |
| 01/29/2004 | US20040019466 Microarray performance management system |
| 01/29/2004 | US20040019437 Chemical structural and compositonal yields model for predicting hydrocarbon thermolysis products |
| 01/29/2004 | US20040019436 Indirect measurement of nitrogen in a multi-component natural gas by heating the gas |
| 01/29/2004 | US20040019435 Methods and systems for analyzing complex biological systems |
| 01/29/2004 | US20040019432 System and method for integrated computer-aided molecular discovery |
| 01/29/2004 | US20040019431 Method of determining an analyte concentration in a sample from an absorption spectrum |
| 01/29/2004 | US20040019430 Methods and systems for analyzing complex biological systems |
| 01/29/2004 | US20040019429 Methods and systems for analyzing complex biological systems |
| 01/29/2004 | US20040019330 Sheath based blood vessel puncture locator and depth indicator |
| 01/29/2004 | US20040019300 Microfluidic blood sample separations |
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019193 Contacting a sample from the patient with an antibody to Mob-5; and detecting the binding of the antibody with antigen in the sample, wherein binding indicates the presence of Mob-5 antigen sample, an indicator of cancer |
| 01/29/2004 | US20040019189 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 01/29/2004 | US20040019109 Methods of identifying compounds that affect a fatty acid cell-surface receptor |
| 01/29/2004 | US20040019104 Bis-phenylarsine derivatives used to label polypeptides and other molecules modified to contain target sequences |
| 01/29/2004 | US20040019060 Drugs such as 9-(3,5-dimethyl-1-piperazinyl)propyl)carbazole, used for modulating endothelial cell proliferation |
| 01/29/2004 | US20040018999 Methods and compositions for RNA interference |
| 01/29/2004 | US20040018983 Binding to zinc finger domain protein |
| 01/29/2004 | US20040018980 Novel FIZZ proteins |
| 01/29/2004 | US20040018979 Anticholesterol agents |
| 01/29/2004 | US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018957 Screening ligands which modulation interaction; antiproliferative agents |
| 01/29/2004 | US20040018643 Encoded random arrays matrices |
| 01/29/2004 | US20040018642 Compositions and methods for capturing, isolating, detecting, analyzing and quantifying macromolecules |
| 01/29/2004 | US20040018641 Detection of contaminants |
| 01/29/2004 | US20040018640 Contamination detection system |
| 01/29/2004 | US20040018639 Using extract from mammal thymus glands; analyzing precipitation patterns |
| 01/29/2004 | US20040018637 Depositing sample on test strips; detection, measurement zones; immunoassay |
| 01/29/2004 | US20040018636 Detecting drug residues; multicolor test strips; colorimetric analysis |
| 01/29/2004 | US20040018630 Destroying ozone by reacting nitrogen oxide; calibrating using ultraviolet absorption |
| 01/29/2004 | US20040018629 Carrier particles sensitized with antibodies; staining with fluorescent dye; applying light source; immunoassay |
| 01/29/2004 | US20040018628 Measuring concentration of organ label; applying liquid to test strips; generating signals; antidiabetic agents, anticancer agents, hypotensive agents, anticonvulsants |
| 01/29/2004 | US20040018613 Method for producing a microarray |
| 01/29/2004 | US20040018612 Electro-optical devices and methods for hybridization and detection |
| 01/29/2004 | US20040018611 Quantitative analysis; labeled fluid flow containing magnetic beads |
| 01/29/2004 | US20040018601 Sequestering, accumulation; immobilized lipid |
| 01/29/2004 | US20040018583 Method of monitoring biofouling in membrane separation systems |
| 01/29/2004 | US20040018580 Serine protease complex; immobilization; anticancer, antitumor agents |
| 01/29/2004 | US20040018579 Dye-labelled peptide and method |
| 01/29/2004 | US20040018577 Multiple hybrid immunoassay |
| 01/29/2004 | US20040018576 Colloid labeled with gold particles; chromatography; analyzing urine |
| 01/29/2004 | US20040018575 Disposable product for analyzing sample; immunoassay; chromatography |
| 01/29/2004 | US20040018572 Mutant Plk protein and gene encoding the same |
| 01/29/2004 | US20040018571 PSCA: prostate stem cell antigen and uses thereof |
| 01/29/2004 | US20040018570 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 01/29/2004 | US20040018568 Reduce immunology response; genetic engineered polypeptide |
| 01/29/2004 | US20040018567 Proteins; antiproliferative agent; autoimmune disease; antiinflammatory agents |
| 01/29/2004 | US20040018566 Modulators of leukocyte activation, BIC compositions and methods of use |
| 01/29/2004 | US20040018565 Contacting with labels; analyzing; amplification of signal |
| 01/29/2004 | US20040018564 Immobilized particles; for measurement |
| 01/29/2004 | US20040018563 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 01/29/2004 | US20040018562 Enzyme as membrane receptor; determining binding |
| 01/29/2004 | US20040018561 Peptide compounds and their use as protease substrates |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018556 Reagent and method for determination of a substance using an immunoaggregator |
| 01/29/2004 | US20040018554 Detection pattern of prion binding; forming antibodies; immunoassay |
| 01/29/2004 | US20040018552 Immobilization; controlling length; coupling to label; biosynthesis |
| 01/29/2004 | US20040018546 Using labeled fluid; medical diagnosis |
| 01/29/2004 | US20040018543 Incubation; controlling temperature and pH |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018540 Evaluation method of interferon beta treatment against multiple sclerosis |
| 01/29/2004 | US20040018538 Mitochondrial dosimeter |
| 01/29/2004 | US20040018535 Determination, calibration; using computer |
| 01/29/2004 | US20040018532 Electronic sensor device |
| 01/29/2004 | US20040018531 Methods of identifying and isolating stem cells and cancer stem cells |
| 01/29/2004 | US20040018528 Cancer diagnosis |
| 01/29/2004 | US20040018527 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemo resistance |
| 01/29/2004 | US20040018526 Labelling Dna; immobilization on substrate; detecting damage |
| 01/29/2004 | US20040018525 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma |
| 01/29/2004 | US20040018519 Anticancer agents; using adsorber; vapor phase spectrometry |
| 01/29/2004 | US20040018517 Uisng fluorescent label; mercurimethyl dihydropsoralen |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018510 Human calcium channel compositions and methods |